Despite Falling Case Numbers, Development Of Zika Vaccine Must Remain Priority

The Lancet Infectious Diseases: Vaccine against Zika virus must remain a priority Editorial Board “…[The] announcement [of Sanofi Pasteur’s decision to withdraw from Zika vaccine R&D] raises concerns about the future of Zika virus vaccine development, at a time when the number of cases is falling and other questions about the virus remain unanswered. ……More

See the article here:
Despite Falling Case Numbers, Development Of Zika Vaccine Must Remain Priority